Solutions to advance life science Harvard Bioscience is a global leader in the manufacture and distribution of solutions to advance life science research. For over 110 years, we have served the changing needs of life scientists in over 100 countries. Our expanding portfolio of brands include instruments for organ and animal research, cell analysis, molecular biology, fluidics, and laboratory consumables. LEARN MORE. Global Brands News Thursday, August 5, 2021 Harvard Bioscience Announces Second Quarter 2021 Financial Results Read the Press Releases Event August 5, 2021, 8:00 am Q2 2021 Harvard Bioscience, Inc. Earnings Conference Call See all events Spotlight Accumulated Inhaled Aerosol (AIA) with DSI’s Buxco Inhalation System The Buxco AIA system provides researchers with real-time aerosol amounts inhaled and deposited in subjects’ lungs, a breakthrough improvement over the current delivered dose measurement. By reporting those measures against real-time respiratory endpoints using FinePointe software, researchers can now observe a direct correlation between dose and lung function over time. Integrating exposure and respiratory capabilities, this system delivers precise amounts of various aerosols to multiple subjects in a uniform, and reproducible manner, then measures pulmonary effects from the same platform. This technology and other new advancements in the Harvard Bioscience inhalation platform provide researchers with novel tools to study COVID-19 and advance development in both the discovery of new therapies and the pre-clinical regulatory phases, as solutions progress toward general clinical use. Learn More Download the Brochure © 2021 Harvard Bioscience All rights reserved Privacy Policy Terms & Conditions Site Map